301089 拓新药业
2025/09 - 九个月
人民币(K¥)
与去年末期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)

非流动资产
长期股权投资0--01,4511,4511,051
投资性房地产0--0000
固定资产816,68864.20%497,386478,348479,786413,520
在建工程40,222-89.21%372,682331,031130,47735,589
无形资产79,733-2.56%81,82784,04284,26184,561
商誉0--0000
其他非流动资产144,32911.59%129,337121,952133,27462,233
1,080,972-0.02%1,081,2321,016,825829,250596,953

流动资产
货币资金69,5560.47%69,234148,554307,092284,196
应收账款78,225-0.46%78,588151,67842,04257,415
存货190,7926.66%178,883204,111241,139167,083
其他流动资产269,821-22.98%350,307317,827423,733288,064
608,394-10.14%677,012822,1701,014,006796,759

流动负债
短期借款0--0040,03464,500
应付票据30,500-11.26%34,37242,16059,08267,621
应付帐款72,907-26.23%98,835110,38999,49895,317
其他流动负债26,437-17.69%32,11741,964225,35027,160
129,843-21.46%165,325194,512423,963254,597
流动资产净值478,550-6.48%511,688627,658590,042542,161
资产总额减流动负债1,559,522-2.10%1,592,9191,644,4821,419,2921,139,114

非流动负债
长期借款0--0000
应付债券0--0000
其他非流动负债37,163-8.01%40,39941,21042,92341,754
37,163-8.01%40,39941,21042,92341,754

总权益
    实收股本126,5450.00%126,545126,545126,000126,000
    储备项目1,395,814-2.12%1,425,9761,476,7271,250,370971,360
股东权益1,522,359-1.94%1,552,5201,603,2721,376,3701,097,360
非控股权益0--0000